Pattern of treatment in metastatic Breast Cancer Patients
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/05/052157
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All individuals above 18 years of age having histopathologically proven, recurrent and/or metastatic triple negative breast cancer (mTNBC) during the period of January 2015 to June 2022.
Patients could have received any number of lines of treatment in the metastatic and/or recurrent setting.
Exclusion Criteria
Patients with breast cancer without triple negative disease.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the treatment pattern and outcomes in patients with recurrent unresectable and/or metastatic triple negative breast cancers.Timepoint: 24 months
- Secondary Outcome Measures
Name Time Method To assess the clinical and radiological profile in patients with metastatic TNBC.Timepoint: 24 months;To assess the patterns of treatment used in the management of recurrent and/or metastatic TNBC.Timepoint: 24 months;To assess the toxicity of treatment in included patients.Timepoint: 24 months;To evaluate the OS in patients with recurrent and/or metastatic TNBC who are treated at the Tata Memorial Hospital and/or ACTREC during the study period.Timepoint: 24 months;To evaluate the PFS in patients with recurrent and/or metastatic TNBC who receive chemotherapy and/or Immunotherapy Targeted therapy during the mentioned study period at the Tata Memorial Hospital and/or ACTREC.Timepoint: 24 months